Page 22 - Beckley Psytech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alexander_Volkov/Getty Images This story is available exclusively to Insider subscribers. Become an Insider and start reading now. The psychedelics industry has ramped up over the past year as institutional investors entered and several companies have gone public. Insider identified the top 14 startups that are working to turn psychedelics into approved medicines for conditions like depression, opioid use disorder, and anxiety.  To put together this article, we reached out to companies on our list from last year, used data pro...

Beckley Psytech This story is available exclusively to Insider subscribers. Become an Insider and start reading now. UK-based psychedelics company Beckley Psytech just closed an $18.6 million funding round, backed by investment firms Noetic Psychedelic Fund and Bail Capital. Beckley Psytech's upcoming clinical trials will be focused on researching the synthetic compound 5-MeO-DMT, a psychedelic agent found naturally in the Sonoran Desert toad. The company says it's preparing to test other compounds as well. Cosmo Feilding Melle...

Reuters Welcome to Insider Cannabis, our weekly newsletter where we're bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar global cannabis boom. Happy Friday readers, Cannabis deal mania continued this week, led by the news that Tilray and Aphria are merging in a $4 billion deal. I spoke to Aphria CEO Irwin Simon and Tilray CEO Brendan Kennedy after the announcement. They said that the merger clearly positions the "new" Tilray as the largest cannabis company by revenue (it just exceeds Curaleaf) and makes it an attr...

Deals of the Week, December 11 to 18 – Growth Business roundup 18 Dec 2020 Growth Business roundup of Deals of the Week December 11 to 18, listing seed funding, venture capital and crowdfunding deals of note Triple support for eXate with three investors raising £2.3m in seed round eXate, a London-based data software firm, has announced a £2.3m seed round led by Outward VC, with additional backing from ING Ventures and Triple Point Ventures. The funding will enable eXate to grow its team, accelerating platform development and expanding into new geographies and verticals. Trip...

Neo Kuma Ventures is a new venture fund in London that's just for investing in psychedelics. Psychedelics are mind-altering substances, like the psilocybin found in magic mushrooms.  Early research suggests that psychedelics could be used to treat health conditions, like mental illnesses resistant to conventional treatments.  Psychedelics is an emerging industry worldwide, separate to cannabis. Canada, the US and Europe are frontrunners. Neo Kuma's 35-year-old co-founder shared her strategy for an emerging and risky field. Clara Burtenshaw had a personal interest in psychedelics that's now ...